Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • RFK Jr.
  • Hantavirus Outbreak
  • AI in Healthcare
  • Makary Resigns
  • Pancreatic Cancer Drug

WHAT'S NEW

  • RFK Jr.
  • Hantavirus Outbreak
  • AI in Healthcare
  • Makary Resigns
  • Pancreatic Cancer Drug

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Dec 20 2023

Full Issue

Viewpoints: Medicaid Unwinding Is Having Grave Effects; FDA Should Be Trusted As Medical Experts

Editorial writers tackle Medicaid unwinding, Mifepristone, alcohol use, and more.

The New York Times: Hey, What Happened To My Health Insurance? 

Tamikka Burks was in an Arkansas emergency room when she found out she had lost her Medicaid coverage. In mid-September, she went in to deal with a cyst in her toe, and someone at the hospital informed her that the state’s Department of Human Services had cut off her coverage on Sept. 1. She felt, she said, “just exhausted. Scared.” (Bryce Covert, 12/20)

The Boston Globe: Mifepristone Challenge Is About More Than Abortion Access — It’s About Keeping Ideological Interests Out Of Fact-Based Decision Making 

By taking up a case that will determine the future availability of mifepristone, half of the two-drug medical abortion regimen that has been administered for more than two decades, the court didn’t just place reproductive rights squarely on its docket for the second time in three years. More broadly, it will determine whether the judgment of FDA experts, based on a broad body of medical scientific research, can be second-guessed in court on the basis of political and religious ideology. (12/20)

Stat: Raise U.S. Federal Alcohol Excise Taxes 

Eleven years ago, two days before Christmas, my 24-year-old brother, who was a university graduate and former law student, died from a self-inflicted gunshot wound. After a decade of hard and continuous drinking interspersed with addiction and mental health treatment, he could not sustain his recovery. His suicide came on the heels of my mother’s death a year before, and just weeks later, my grandfather died in a car accident. My family’s holidays would never be the same. Like so many others who survived the loss of someone dear from the chaos of severe substance use disorder (SUD), I am too familiar with unspeakable grief. But I have found meaning through it and purpose in passing that on. (Cara Poland, 12/20)

Chicago Tribune: Curbing Exposure To Weed And Alcohol Marketing Can Improve Teens' Mental Health

There is so much dismal news about young people struggling with mental health problems, suicide, fentanyl, vaping, social media, pornography and online gambling. Yet we continue to overlook one of the most effective and expedient ways to address these problems: regulatory action to curb youth exposure and access to addictive, unhealthy influences purportedly meant for adults only. (Aaron Weiner and Linda Richter, 12/20)

St. Louis Post-Dispatch: Diapers And Feminine Hygiene Products Are Not 'Luxuries'

State lawmakers from both sides of the aisle are invested in the issue of luxury sales tax on feminine hygiene products and diapers, which means they must be hearing from their constituents that this is an important matter to Missourians. In Missouri, both feminine hygiene products and diapers are taxed as tangible personal property at a rate 4.225%. These basic necessities are being taxed as luxuries, while other necessities — such as groceries — are taxed at a reduced rate of 1.225%. Prescription medications and other medical products, such as hearing aids, are exempt from sales tax entirely. (Marilou Jackson, 12/19)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 13
  • Tuesday, May 12
  • Monday, May 11
  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF